Caffeine therapy improves the rate of survival without neurodevelopmental disability in preterm babies

Ciobanu, Andrea
September 2007
Maedica - a Journal of Clinical Medicine;2007, Vol. 2 Issue 3, p259
Academic Journal
The article presents a study on the effects of caffeine therapy on the development of preterm infants. It states that caffeine and other methylxanthines-amino-phylline and theophylline have been administered to preterm infants, and this is the first important study meant to clear the uncertainty concerning the efficacy and safety of methylxanthine therapy in preterm babies suffering from apnea of prematurity. It is also concluded that caffeine reduces the rate of bronchopulmonary dysplasia at almost 2 years in infants with very low birth weight, improving the rate of survival without neurodevelopmental disability.


Related Articles

  • Caffeine for the management of apnea in preterm infants Mueni, Eunice; Opiyo, Newton; English, Mike // International Health (1876-3413);Dec2009, Vol. 1 Issue 2, p190 

    Summary: Considerable uncertainty persists regarding the efficacy and safety of methylxanthines (caffeine, theophylline – in intravenous form named aminophylline) for the prevention and treatment of infant apnea. To help inform national guideline development in Kenya we undertook...

  • The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children. Ji Hyuk Lee; Mi Jin Kim; Jong Seung Lee; Yon Ho Choe // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jan2011, Vol. 96 Issue 1, p9 

    Objectives The purpose of this 24-week treatment study was to evaluate the effects of three treatment strategies after 8 weeks of lansoprazole therapy for gastroesophageal reflux disease in children. Design Open-labelled, uncontrolled, prospective study. Setting Samsung Medical Center, Seoul,...

  • Caffeine for premmies. Kelly, Elizabeth; Fallows, Carol // Australia's Parents;Dec96/Jan97, Issue 96, p57 

    Reports on a new study at the University of Queensland which found that caffeine is an effective treatment for apnoea in premmies.

  • Caffeine dominant and perks up premature infants.  // PharmacoEconomics & Outcomes News;2/19/2011, Issue 622, p1 

    The article focuses on research from the Caffeine for Apnea of Prematurity (CAP) Trial Group regarding the role of caffeine in the treatment of apnoea in low-birth weight premature infants.

  • Terapia Respiratória na Displasia Broncopulmonar. Manzano, Roberta Munhoz; Sampaio, Lourdes Jaqueline; dos Santos, Débora Cristina // Revista Inspirar Movimento & Saude;mar/abr2012, Vol. 4 Issue 2, p16 

    Bronchopulmonary dysplasia affects preterm newborn underwent aggressive mechanical ventilation or high oxygen concentrations. With the emergence of new respiratory therapies in obstetric and neonatal care, there was a reduced mortality and increased of survival in very or extreme low birth...

  • On the Caffeination of Prematurity. Stevenson, David K. // New England Journal of Medicine;11/8/2007, Vol. 357 Issue 19, p1967 

    This editorial comments on a study in this issue on the use of caffeine in the treatment of premature infants with apnea. The study showed a positive and safe effect of caffeine for this use and the author discusses why it may work so well. Even with what is known, at least half of the effect of...

  • Sequential updating of a new dynamic pharmacokinetic model for caffeine in premature neonates. Micallef, Sandrine; Amzal, Billy; Bach, Véronique; Chardon, Karen; Tourneux, Pierre; Bois, Frédéric Y.; Bach, Véronique; Bois, Frédéric Y // Clinical Pharmacokinetics;2007, Vol. 46 Issue 1, p59 

    Background and Objective: Caffeine treatment is widely used in nursing care to reduce the risk of apnoea in premature neonates. To check the therapeutic efficacy of the treatment against apnoea, caffeine concentration in blood is an important indicator. The present study was aimed...

  • Food for thought: A coffee a day keeps dementia at bay.  // Active Living: Newsletters;May2008, p27 

    The article reports on the research concerning the benefits of caffeine in Canada. The research suggests that caffeine may protect against memory decline in people with Alzheimer's disease. Moreover, the study reveals that the inverse relationship between coffee intake and the risk of developing...

  • Long-Term Effects of Caffeine Therapy for Apnea of Prematurity. Schmidt, Barbara; Roberts, Robin S.; Davis, Peter; Doyle, Lex W.; Barrington, Keith J.; Ohlsson, Arne; Solimano, Alfonso; Tin, Win // New England Journal of Medicine;11/8/2007, Vol. 357 Issue 19, p1893 

    Background: Methylxanthine therapy is commonly used for apnea of prematurity but in the absence of adequate data on its efficacy and safety. It is uncertain whether methylxanthines have long-term effects on neurodevelopment and growth. Methods: We randomly assigned 2006 infants with birth...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics